Kintara Therapeutics, Inc

(NASDAQ:DMPI)

Latest On Kintara Therapeutics, Inc (DMPI):

Date/Time Type Description Signal Details
2021-02-14 07:29 ESTFinancialsCompany financials have been released.Neutral
2020-12-06 23:33 ESTFinancialsCompany financials have been released.Neutral
2020-11-26 19:46 ESTFinancialsCompany financials have been released.Neutral
2020-11-20 03:49 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 03:46 ESTFinancialsCompany financials have been released.Neutral
2020-11-07 15:37 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 12:34 ESTFinancialsCompany financials have been released.Neutral
2020-09-25 00:35 ESTFinancialsCompany financials have been released.Neutral
2020-09-24 00:41 ESTFinancialsCompany financials have been released.Neutral
2020-09-23 00:44 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 04:42 ESTFinancialsCompany financials have been released.Neutral
2020-08-31 20:33 ESTFinancialsCompany financials have been released.Neutral
2020-08-21 16:49 ESTInsider TradeKeith Murphy has directly acquired 181,010 shares and currently holds 181,010 shares.Buy
2020-08-21 16:49 ESTInsider TradeJohn Liatos has directly acquired 196,750 shares and currently holds 196,750 shares.Buy
2020-08-19 11:14 ESTNewsDelMar Pharma announces ~$20M capital raiseN/A
2020-08-18 06:29 ESTNewsDelmar +7.8% PM, stockholders approve all proposals regarding Delmar and Adgero mergerN/A
2020-08-14 08:36 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 00:47 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 16:49 ESTFinancialsCompany financials have been released.Neutral
2020-07-17 16:14 ESTNewsDenovo Biopharma's enzastaurin Fast Track'd for brain tumorN/A
2020-07-09 08:32 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 08:34 ESTFinancialsCompany financials have been released.Neutral
2020-06-25 10:24 ESTNewsDelMar Pharma secures $500K loan to support advancement of VAL-083N/A
2020-06-23 00:18 ESTNewsDelMar Pharma down 17% on underwhelming VAL-083 dataN/A
2020-06-12 04:33 ESTFinancialsCompany financials have been released.Neutral
2020-06-11 05:28 ESTNewsDelMar Pharma rallies on acquisition of Adgero BioN/A
2020-05-27 04:36 ESTFinancialsCompany financials have been released.Neutral
2020-05-17 20:34 ESTFinancialsCompany financials have been released.Neutral
2020-05-13 11:36 ESTNewsDelMar Pharmaceuticals EPS misses by $0.01N/A
2020-05-06 04:38 ESTFinancialsCompany financials have been released.Neutral
2020-05-03 08:40 ESTFinancialsCompany financials have been released.Neutral
2020-04-11 12:30 ESTNewsDelMar Pharmaceuticals EPS beats by $0.10N/A
2020-04-11 12:26 ESTNewsDelMar Pharma up 4% advancement of VAL-083 studyN/A
2020-04-10 00:32 ESTFinancialsCompany financials have been released.Neutral
2020-04-07 00:47 ESTFinancialsCompany financials have been released.Neutral
2020-03-22 00:29 ESTFinancialsCompany financials have been released.Neutral
2020-02-28 03:38 ESTFinancialsCompany financials have been released.Neutral
2020-02-27 20:03 ESTFinancialsCompany financials have been released.Neutral
2020-02-15 23:27 ESTFinancialsCompany financials have been released.Neutral
2020-02-14 23:30 ESTFinancialsCompany financials have been released.Neutral
2020-02-14 03:27 ESTEarningsEarnings have been released on February 13, 2020, with -$0.15 earnings per share.Buy
2020-02-14 03:27 ESTEarnings EstimateAn EPS average of -$0.12 is estimated for the quarter ending on March 31, 2020.Buy
2020-02-12 23:28 ESTFinancialsCompany financials have been released.Neutral
2020-02-06 23:33 ESTFinancialsCompany financials have been released.Neutral
2020-01-31 23:30 ESTFinancialsCompany financials have been released.Neutral
2020-01-29 23:33 ESTFinancialsCompany financials have been released.Neutral
2020-01-28 03:39 ESTEarningsEarnings have been released on February 12, 2019, with -$0.75 earnings per share.Buy
2020-01-28 03:39 ESTEarningsEarnings have been released on November 14, 2018, with -$0.88 earnings per share.Buy
2020-01-28 03:39 ESTEarningsEarnings have been released on September 10, 2019, with -$0.89 earnings per share.Sell
2020-01-28 03:39 ESTEarningsEarnings have been released on May 15, 2019, with -$0.67 earnings per share.Buy

About Kintara Therapeutics, Inc (DMPI):

DelMar Pharmaceuticals, Inc., a clinical stage drug development company, focuses on developing and commercializing anti-cancer therapies to treat cancer patients. Its product candidate is VAL-083, a DNA-targeting agent, which is in Phase II clinical study for the treatment of drug-resistant solid tumors, such as glioblastoma multiforme, as well as other solid tumors, including ovarian cancer, non-small cell lung cancer, and diffuse intrinsic pontine glioma. The company has a strategic collaboration with Guangxi Wuzhou Pharmaceutical (Group) Co. Ltd. to manufacture and sell VAL-083 in China; and Duke University to evaluate VAL-083 as a front-line treatment for newly diagnosed patients with GBM. DelMar Pharmaceuticals, Inc. was founded in 2009 and is headquartered in San Diego, California.

DMPI Quotes by TradingView

See Advanced Chart

General

  • Name Kintara Therapeutics, Inc
  • Symbol DMPI
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 2
  • Last Split Factor1:10
  • Last Split Date2019-05-08
  • Fiscal Year EndJune
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.delmarpharma.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 11.02
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Return on Assets -137%
  • Earnings Per Share -$3.16
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 15.35 million
  • EBITDA -8382147
  • Analyst Target Price $3
  • Book Value Per Share $0.20
View More

Share Statistics

  • Shares Outstanding 11.46 million
  • Shares Float 10.64 million
  • % Held by Insiders 144%
  • % Held by Institutions 12.46%
  • Shares Short 211710
  • Shares Short Prior Month 458076
  • Short Ratio 0.24
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 1.85
  • 52 Week High $2.5
  • 52 Week Low $0.38
  • 50 Day Moving Average 1.49
  • 200 Day Moving Average 1.36
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
View More

Kintara Therapeutics, Inc (DMPI) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Kintara Therapeutics, Inc (DMPI) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-12$N/A-$1.33-$0.09-1377.78%
2020-06-302020-09-08$N/A-$0.33-$0.13-153.85%
2020-03-312020-05-13$N/A-$0.17-$0.12-41.67%
2019-12-312020-02-13$N/A-$0.15-$0.1711.76%
2019-09-302019-11-13$N/A-$0.21
2019-06-302019-09-09$N/A-$0.89-$0.61-45.9%
2019-03-312019-05-14$N/A-$0.67
2018-12-312019-02-11$N/A-$0.75
2018-09-302018-11-13$N/A-$0.88
2018-06-302018-09-24$N/A-$1.00-$1.109.09%
2018-03-312018-05-15$N/A-$1.30-$1.00-30%
2017-12-312018-02-14$N/A-$1.40-$1.506.67%
2017-09-302017-11-09$N/A-$1.80-$1.70-5.88%
2017-06-302017-09-27$N/A-$0.20-$0.16-25%
2017-03-312017-05-12$N/A-$0.18-$0.14-28.57%
2016-12-312017-02-10$N/A-$0.13-$0.2240.91%
2016-09-302016-11-14$N/A-$0.23-$0.15-53.33%
2016-06-302016-09-13$N/A-$0.32-$0.19-68.42%
2016-03-312016-05-13$N/A-$0.12-$0.1936.84%
2015-12-312016-02-12$N/A-$0.24-$0.12-100%
2015-09-302015-11-16$N/A-$0.16-$0.12-33.33%
2015-06-302015-09-04$N/A-$0.30
2015-03-312015-05-18$N/A-$0.12-$0.3262.5%
2014-12-312015-02-12$N/A-$0.08-$0.2466.67%
2014-09-302014-11-10$N/A-$1.45
2014-06-302014-08-29$N/A$4.03
2014-03-312014-03-31$N/A-$4.04
2013-12-312014-03-10$N/A-$0.80-$2.0060%
2013-09-302013-09-30$N/A$6.52
2013-06-302013-06-30$N/A-$8.80
2013-03-312013-03-31$N/A-$12.18

Kintara Therapeutics, Inc (DMPI) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Kintara Therapeutics, Inc (DMPI) Chart:

Kintara Therapeutics, Inc (DMPI) News:

Below you will find a list of latest news for Kintara Therapeutics, Inc (DMPI) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Kintara Therapeutics, Inc (DMPI) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Kintara Therapeutics, Inc (DMPI) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-07-02424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1498382/000119312520186917/0001193125-20-186917-index.htm
2020-06-23UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1498382/000000000020005608/0000000000-20-005608-index.htm
2020-01-23SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1498382/000090266420000411/0000902664-20-000411-index.htm
2019-09-194/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571819000779/0000905718-19-000779-index.htm
2019-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571819000809/0000905718-19-000809-index.htm
2019-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571819000811/0000905718-19-000811-index.htm
2019-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571819000813/0000905718-19-000813-index.htm
2019-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571819000815/0000905718-19-000815-index.htm
2019-10-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571819000817/0000905718-19-000817-index.htm
2019-11-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571819000941/0000905718-19-000941-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000012/0000905718-20-000012-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000014/0000905718-20-000014-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000016/0000905718-20-000016-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000018/0000905718-20-000018-index.htm
2020-01-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000020/0000905718-20-000020-index.htm
2020-08-27DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000905/0000905718-20-000905-index.htm
2020-08-28DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000907/0000905718-20-000907-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000961/0000905718-20-000961-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000963/0000905718-20-000963-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000965/0000905718-20-000965-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000967/0000905718-20-000967-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000969/0000905718-20-000969-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000971/0000905718-20-000971-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000973/0000905718-20-000973-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000975/0000905718-20-000975-index.htm
2020-09-244/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000982/0000905718-20-000982-index.htm
2020-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000984/0000905718-20-000984-index.htm
2020-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000997/0000905718-20-000997-index.htm
2020-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000998/0000905718-20-000998-index.htm
2020-09-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000090571820000999/0000905718-20-000999-index.htm
2020-02-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1498382/000110465920013406/0001104659-20-013406-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1498382/000119312520038091/0001193125-20-038091-index.htm
2020-06-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000119312520165187/0001193125-20-165187-index.htm
2020-06-10425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1498382/000119312520165188/0001193125-20-165188-index.htm
2020-06-16S-4Registration of securities, business combinationshttps://www.sec.gov/Archives/edgar/data/1498382/000119312520170505/0001193125-20-170505-index.htm
2020-06-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000119312520177765/0001193125-20-177765-index.htm
2020-06-24425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1498382/000119312520177766/0001193125-20-177766-index.htm
2020-06-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000119312520181055/0001193125-20-181055-index.htm
2020-06-30CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1498382/000119312520184125/0001193125-20-184125-index.htm
2020-07-02S-4/ARegistration of securities, business combinationshttps://www.sec.gov/Archives/edgar/data/1498382/000119312520185478/0001193125-20-185478-index.htm
2020-07-02424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1498382/000119312520186917/0001193125-20-186917-index.htm
2019-09-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000121390019019207/0001213900-19-019207-index.htm
2019-10-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000121390019019391/0001213900-19-019391-index.htm
2019-11-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1498382/000121390019023215/0001213900-19-023215-index.htm
2019-11-15POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1498382/000121390019023736/0001213900-19-023736-index.htm
2019-11-15POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1498382/000121390019023744/0001213900-19-023744-index.htm
2019-11-21424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1498382/000121390019024249/0001213900-19-024249-index.htm
2019-11-21424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1498382/000121390019024251/0001213900-19-024251-index.htm
2019-11-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000121390019024405/0001213900-19-024405-index.htm
2020-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000121390020000327/0001213900-20-000327-index.htm
2020-02-11SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020003194/0001213900-20-003194-index.htm
2020-02-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1498382/000121390020003470/0001213900-20-003470-index.htm
2020-02-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000121390020003471/0001213900-20-003471-index.htm
2020-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000121390020007428/0001213900-20-007428-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020008213/0001213900-20-008213-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020008214/0001213900-20-008214-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020008217/0001213900-20-008217-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020008219/0001213900-20-008219-index.htm
2020-03-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020008229/0001213900-20-008229-index.htm
2020-04-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000121390020009703/0001213900-20-009703-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1498382/000121390020011910/0001213900-20-011910-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000121390020011912/0001213900-20-011912-index.htm
2020-06-02DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020013923/0001213900-20-013923-index.htm
2020-06-08DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1498382/000121390020014311/0001213900-20-014311-index.htm
2020-06-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1498382/000121390020014692/0001213900-20-014692-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020016299/0001213900-20-016299-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020016303/0001213900-20-016303-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020016306/0001213900-20-016306-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020016308/0001213900-20-016308-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020016310/0001213900-20-016310-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020016315/0001213900-20-016315-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020016317/0001213900-20-016317-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020016319/0001213900-20-016319-index.htm
2020-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020016559/0001213900-20-016559-index.htm
2020-07-28425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020018865/0001213900-20-018865-index.htm
2020-08-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000121390020022409/0001213900-20-022409-index.htm
2020-08-17425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020022410/0001213900-20-022410-index.htm
2020-08-18425Prospectuses and communications, business combinationshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020022614/0001213900-20-022614-index.htm
2020-08-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020023261/0001213900-20-023261-index.htm
2020-08-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020023264/0001213900-20-023264-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020023271/0001213900-20-023271-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1498382/000121390020023272/0001213900-20-023272-index.htm
2020-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000121390020023287/0001213900-20-023287-index.htm
2020-08-248-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000121390020023471/0001213900-20-023471-index.htm
2020-08-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000121390020023568/0001213900-20-023568-index.htm
2020-09-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000121390020024674/0001213900-20-024674-index.htm
2020-08-28SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1498382/000149315220016923/0001493152-20-016923-index.htm
2020-01-21SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1498382/000153561020000042/0001535610-20-000042-index.htm
2020-09-1810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1498382/000156459020044019/0001564590-20-044019-index.htm
2020-09-21S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1498382/000156459020044027/0001564590-20-044027-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1498382/000156459020044055/0001564590-20-044055-index.htm
2020-10-26S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1498382/000156459020047646/0001564590-20-047646-index.htm
2020-11-04424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1498382/000156459020050543/0001564590-20-050543-index.htm
2019-11-20EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1498382/999999999519002617/9999999995-19-002617-index.htm
2019-11-20EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1498382/999999999519002618/9999999995-19-002618-index.htm
2020-07-02EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1498382/999999999520001631/9999999995-20-001631-index.htm
2020-11-04EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1498382/999999999520003083/9999999995-20-003083-index.htm

Kintara Therapeutics, Inc (DMPI) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Kintara Therapeutics, Inc (DMPI). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 144%
Institutional Ownership: 1246%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-08-19Keith MurphyDirectorBuy181,010.00181,010.00https://www.sec.gov/Archives/edgar/data/1498382/000121390020023271/0001213900-20-023271-index.htm
2020-08-19John LiatosSVP, Business DevelopmentBuy196,750.00196,750.00https://www.sec.gov/Archives/edgar/data/1498382/000121390020023272/0001213900-20-023272-index.htm